IMTX
NASDAQ · Biotechnology
Immatics Nv
$9.78
+0.58 (+6.30%)
Open$9.27
Previous Close$9.20
Day High$9.89
Day Low$9.27
52W High$12.41
52W Low$3.30
Volume—
Avg Volume375.5K
Market Cap1.36B
P/E Ratio—
EPS$-0.96
SectorBiotechnology
Analyst Ratings
Strong Buy
17 analysts
Price Target
+689.9% upside
Current
$9.78
$9.78
Target
$77.25
$77.25
$52.47
$77.25 avg
$103.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 202.41M | 122.80M | 330.72M |
| Net Income | 19.77M | 10.79M | -35,950,365 |
| Profit Margin | 9.8% | 9.3% | -10.9% |
| EBITDA | -38,714,040 | -22,312,890 | -62,958,224 |
| Free Cash Flow | — | — | -53,039,983 |
| Rev Growth | +64.8% | +64.8% | -2.7% |
| Debt/Equity | 0.03 | 0.03 | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |